Table 2.

Proportion of probable/definite FH in subgroups of patients included in the registry because of FH versus ASCVD, according to known standardized clinical definitions of FH

	Dutch Lipid Clinic Network	Simon Broome Register	Canadian definition for FH
REACT cohort (n = 195)	49.5%	54.7%	61.5%
Subgroups: FH (n = 109)	61.7%	79.4%	78.5%
ASCVD (n = 86)	34.1%	23.5%	40.0%

ASCVD, atherosclerotic cardiovascular disease; FH, familial hypercholesterolemia; REACT, Relating Evidence to Achieve Cholesterol Targets.